Pacira sues FDA over pain drug marketing restrictions

By Brendan Pierson, Published on Reuters on September 8th, 2015 New York – Pacira Pharmaceuticals Inc on Tuesday filed a lawsuit seeking a court order allowing it to promote its post-surgery pain drug, Exparel, for a wide range of surgeries, which the U.S. Food and Drug Administration opposes. [ Read More ]

Related Event:

Promotional Review Compliance for Drugs & Devices

ACI is pleased to bring you our summit on Drug and Device Advertising and Promotional Review Compliance on January 11-13, 2016 in Philadelphia, PA. Designed from industry input, this advanced program will help you understand the best practices in advertising and promotions from the nation’s top companies.

Click here to learn more.